A Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases

NCT04299646 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma
Radiotherapy

Interventions

RADIATION: Steretactic radiotherapy

Sponsor

Centre Francois Baclesse

Collaborators

[object Object]
[object Object]